These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9271706)

  • 1. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis.
    Caputi M; De Luca L; Papaccio G; D'Aponte A; Cavallotti I; Scala P; Scarano F; Manna M; Gualdiero L; De Luca B
    Eur J Histochem; 1997; 41(2):133-8. PubMed ID: 9271706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
    Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
    Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E; Moro D; Gazzeri S; Brambilla C
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
    Keum JS; Kong G; Yang SC; Shin DH; Park SS; Lee JH; Lee JD
    Br J Cancer; 1999 Sep; 81(1):127-32. PubMed ID: 10487623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation.
    Mate JL; Ariza A; Aracil C; López D; Isamat M; Pérez-Piteira J; Navas-Palacios JJ
    J Pathol; 1996 Dec; 180(4):395-9. PubMed ID: 9014860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
    Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
    Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung.
    Ikehara M; Oshita F; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
    Oncol Rep; 2003; 10(1):137-9. PubMed ID: 12469159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report].
    Kosacka M; Korzeniewska A; Jankowska R
    Pol Merkur Lekarski; 2010 Feb; 28(164):117-21. PubMed ID: 20369739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
    Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
    Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignancy of colorectal cancer analyzed by expression of cyclin D1].
    Maeda K; Kang SM; Ogawa M; Chung YS; Onoda N; Nakata B; Nishiguchi Y; Ikehara T; Okuno M; Sowa M
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():259-62. PubMed ID: 9263512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
    van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
    Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.